| Year |
Citation |
Score |
| 2016 |
Gönczi L, Kürti Z, Golovics P, Végh Z, Lovász B, Dorkó A, Seres A, Sümegi L, Menyhárt O, Kiss L, Papp J, Gecse K, Lakatos PL. [Indications, diagnoses and quality markers in upper and lower endoscopies in 2010 and 2011 at the 1st Department of Medicine, Semmelweis University, Budapest]. Orvosi Hetilap. 157: 2074-2081. PMID 28019112 DOI: 10.1556/650.2016.30602 |
0.447 |
|
| 2015 |
Kurti Z, Lovasz BD, Gecse KB, Balint A, Farkas K, Morocza-Szabo A, Gyurcsanyi A, Kristof K, Vegh Z, Gonczi L, Kiss LS, Golovics PA, Lakatos L, Molnar T, Lakatos PL. Tuberculin Skin Test and Quantiferon in BCG Vaccinated, Immunosuppressed Patients with Moderate-to-Severe Inflammatory Bowel Disease. Journal of Gastrointestinal and Liver Diseases : Jgld. 24: 467-72. PMID 26697573 DOI: 10.15403/Jgld.2014.1121.244.Bcg |
0.539 |
|
| 2015 |
Golovics PA, Lakatos L, Mandel MD, Lovasz BD, Vegh Z, Kurti Z, Szita I, Kiss LS, Balogh M, Pandur T, Lakatos PL. Does Hospitalization Predict the Disease Course in Ulcerative Colitis? Prevalence and Predictors of Hospitalization and Re-Hospitalization in Ulcerative Colitis in a Population-based Inception Cohort (2000-2012). Journal of Gastrointestinal and Liver Diseases : Jgld. 24: 287-92. PMID 26405700 DOI: 10.15403/Jgld.2014.1121.243.Pag |
0.554 |
|
| 2015 |
Golovics PA, Lakatos L, Mandel MD, Lovasz BD, Vegh Z, Kurti Z, Szita I, Kiss LS, Pandur T, Lakatos PL. Prevalence and predictors of hospitalization in Crohn's disease in a prospective population-based inception cohort from 2000-2012. World Journal of Gastroenterology : Wjg. 21: 7272-80. PMID 26109815 DOI: 10.3748/Wjg.V21.I23.7272 |
0.57 |
|
| 2015 |
Kurti Z, Lovasz BD, Mandel MD, Csima Z, Golovics PA, Csako BD, Mohas A, Gönczi L, Gecse KB, Kiss LS, Szathmari M, Lakatos PL. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe. World Journal of Gastroenterology : Wjg. 21: 6728-35. PMID 26074711 DOI: 10.3748/Wjg.V21.I21.6728 |
0.464 |
|
| 2015 |
Golovics PA, Lakatos L, Mandel MD, Lovasz BD, Vegh Z, Kurti Z, Szita I, Kiss LS, Balogh M, Pandur T, Lakatos PL. Does hospitalization predict the disease course in ulcerative colitis? Prevalence and predictors of hospitalization and rehospitalization in ulcerative colitis in a population-based inception cohort (2000-2012) Journal of Gastrointestinal and Liver Diseases. 24: 287-292. DOI: 10.15403/jgld.2014.1121.243.pag |
0.362 |
|
| 2015 |
Kürti Z, Rutka M, Farkas K, Sipeki N, Golovics P, Lovász B, Végh Z, Gecse K, Kiss L, Altorjay I, Papp M, Molnár T, Lakatos P. Accelerated treatment strategy in inflammatory bowel diseases; is it associated with a change in the disease course? Zeitschrift FüR Gastroenterologie. 53. DOI: 10.1055/S-0035-1551868 |
0.51 |
|
| 2015 |
Golovics PA, Farkas K, Sipeki N, Kurti Z, Rutka M, Kiss LS, Lovasz BD, Vegh Z, Gecse K, Altorjay I, Papp M, Molnar T, Lakatos PL. Sa1156 Accelerated Treatment Strategy in Inflammatory Bowel Diseases; Is It Associated With a Change in the Disease Course? Gastroenterology. 148: S-242-S-243. DOI: 10.1016/S0016-5085(15)30796-4 |
0.511 |
|
| 2014 |
Mandel MD, Balint A, Golovics PA, Vegh Z, Mohas A, Szilagyi B, Szabo A, Kurti Z, Kiss LS, Lovasz BD, Gecse KB, Farkas K, Molnar T, Lakatos PL. Decreasing trends in hospitalizations during anti-TNF therapy are associated with time to anti-TNF therapy: Results from two referral centres. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. 46: 985-90. PMID 25156871 DOI: 10.1016/J.Dld.2014.07.168 |
0.55 |
|
| 2014 |
Farkas K, Lakatos PL, Szűcs M, Pallagi-Kunstár É, Bálint A, Nagy F, Szepes Z, Vass N, Kiss LS, Wittmann T, Molnár T. Frequency and prognostic role of mucosal healing in patients with Crohn's disease and ulcerative colitis after one-year of biological therapy. World Journal of Gastroenterology : Wjg. 20: 2995-3001. PMID 24659890 DOI: 10.3748/wjg.v20.i11.2995 |
0.544 |
|
| 2014 |
Lovasz BD, Lakatos L, Horvath A, Pandur T, Erdelyi Z, Balogh M, Szipocs I, Vegh Z, Veres G, Müller KE, Golovics PA, Kiss LS, Mandel MD, Lakatos PL. Incidence rates and disease course of paediatric inflammatory bowel diseases in Western Hungary between 1977 and 2011. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. 46: 405-11. PMID 24495511 DOI: 10.1016/J.Dld.2013.12.013 |
0.66 |
|
| 2014 |
Lovász B, Lakatos L, Horváth Á, Pandúr T, Erdélyi Z, Balogh M, Szipocs I, Végh Z, Veres G, Golovics P, Kiss L, Mandel M, Lakatos P. Incidence rates and disease course of pediatric inflammatory bowel diseases in western Hungary between 1977 – 2011 Zeitschrift Fur Gastroenterologie. 52. DOI: 10.1055/S-0034-1376099 |
0.535 |
|
| 2014 |
Lakatos P, Golovics P, Mandel M, Kürti Z, Szita I, Végh Z, Kiss L, Horváth Á, Pandur T, Balogh M, Mohás A, Lovász B, Lakatos L. Is hospitalization predicting the disease course in UC? Prevalence and predictors of hospitalization and re-hospitalization in ulcerative colitis in a population-based inception cohort between 2000 – 2012 Zeitschrift FüR Gastroenterologie. 52. DOI: 10.1055/S-0034-1376095 |
0.413 |
|
| 2014 |
Golovics P, Bálint A, Mandel M, Végh Z, Mohás A, Szilágyi B, Szabó Á, Kürti Z, Kiss L, Gecse K, Lovász B, Farkas K, Molnár T, Lakatos P. Hospitalization rate before and after anti-TNF therapy, results from two referral centers Zeitschrift FüR Gastroenterologie. 52. DOI: 10.1055/S-0034-1376079 |
0.344 |
|
| 2014 |
Gecse K, Kürti Z, Lovász B, Szabó Á, Mandel M, Gyurcsányi A, Kristóf K, Végh Z, Mohás A, Csákó B, Kiss L, Golovics P, Lakatos P. Is the tuberculin skin test alone accurate in moderate-to-severe BCG vaccinated patients with inflammatory bowel disease treated with immunosuppressives to test for latent tuberculosis? Zeitschrift FüR Gastroenterologie. 52. DOI: 10.1055/S-0034-1376076 |
0.385 |
|
| 2014 |
Golovics P, Balint A, Mandel M, Vegh Z, Mohas A, Szilagyi B, Szabo A, Kurti Z, Kiss L, Lovasz B, Farkas K, Molnar T, Lakatos P. P468 Hospitalization rate before and after anti-TNF therapy, results from two referral centers Journal of Crohn's and Colitis. 8: S261. DOI: 10.1016/S1873-9946(14)60588-2 |
0.495 |
|
| 2014 |
Golovics P, Szabo A, Mandel M, Gyurcsanyi A, Kristof K, Vegh Z, Mohas A, Szilagyi B, Kurti Z, Csako B, Kiss L, Lovasz B, Gecse K, Lakatos P. P197 Is the tuberculin skin test alone accurate in moderate-to-severe BCG vaccinated patients with inflammatory bowel disease to test for latent tuberculosis? Journal of Crohn's and Colitis. 8: S144. DOI: 10.1016/S1873-9946(14)60318-4 |
0.523 |
|
| 2014 |
Golovics P, Mandel M, Lovasz B, Vegh Z, Szita I, Kiss L, Balogh M, Mohas A, Szilagyi B, Pandur T, Lakatos L, Lakatos P. DOP048 Is hospitalization predicting the disease course in Crohn's disease? Prevalence and predictors of hospitalization and re-hospitalization in Crohn's disease in a population based inception cohort between 2000–2012 Journal of Crohn's and Colitis. 8: S37-S38. DOI: 10.1016/S1873-9946(14)60073-8 |
0.608 |
|
| 2014 |
Lovasz B, Mandel M, Golovics P, Szita I, Vegh Z, Kiss L, Horvath A, Pandur T, Balogh M, Mohas A, Szilagyi B, Lakatos L, Lakatos P. DOP047 Is hospitalization predicting the disease course in UC? Prevalence and predictors of hospitalization and re-hospitalization in ulcerative colitis in a population-based inception cohort between 2000–2012 Journal of Crohn's and Colitis. 8: S37. DOI: 10.1016/S1873-9946(14)60072-6 |
0.545 |
|
| 2014 |
Mandel M, Balint A, Lovasz B, Kiss L, Golovics P, Vegh Z, Farkas K, Molnar T, Mohas A, Szilagyi B, Lakatos P. DOP027 Work disability in patients with inflammatory bowel diseases. Final report from two referral centers Journal of Crohn's and Colitis. 8: S27. DOI: 10.1016/S1873-9946(14)60052-0 |
0.618 |
|
| 2014 |
Golovics PA, Balint A, Mandel MD, Vegh Z, Mohas A, Szilagyi B, Szabo A, Kurti Z, Kiss LS, Lovasz BD, Farkas K, Molnar T, Lakatos PL. Su1332 Hospitalization Rate Before and After Anti-TNF Therapy, Results From Two Referral Centers Gastroenterology. 146: S-438. DOI: 10.1016/S0016-5085(14)61576-6 |
0.343 |
|
| 2014 |
Golovics PA, Mandel MD, Lovasz BD, Vegh Z, Szita I, Kiss LS, Mohas A, Szilagyi B, Lakatos L, Lakatos PL. Su1331 Is Hospitalization Predicting the Disease Course in Crohn's Disease? Prevalence and Predictors of Hospitalization and Re-Hospitalization in Crohn's Disease in a Population Based Inception Cohort Between 2000-2012 Gastroenterology. 146: S-438. DOI: 10.1016/S0016-5085(14)61575-4 |
0.496 |
|
| 2013 |
Golovics PA, Lakatos L, Nagy A, Pandur T, Szita I, Balogh M, Molnar C, Komaromi E, Lovasz BD, Mandel M, Veres G, Kiss LS, Vegh Z, Lakatos PL. Is early limited surgery associated with a more benign disease course in Crohn's disease? World Journal of Gastroenterology : Wjg. 19: 7701-10. PMID 24282358 DOI: 10.3748/Wjg.V19.I43.7701 |
0.609 |
|
| 2013 |
Lovasz BD, Lakatos L, Golovics PA, David G, Pandur T, Erdelyi Z, Balogh M, Szita I, Molnar C, Komaromi E, Vegh Z, Mandel MD, Kiss LS, Lakatos PL. Risk of colorectal cancer in Crohn's disease patients with colonic involvement and stenosing disease in a population-based cohort from Hungary. Journal of Gastrointestinal and Liver Diseases : Jgld. 22: 265-8. PMID 24078982 |
0.56 |
|
| 2013 |
Kiss LS, Lovasz BD, Golovics PA, Vegh Z, Farkas K, Molnar T, Palatka K, Papp M, Mohas A, Szilagyi BK, Fekete SA, Mandel M, Lakatos PL. Levels of anti-double-strained DNA but not antinuclear antibodies are associated with treatment efficacy and adverse outcomes in Crohn's disease patients treated with anti-TNFα. Journal of Gastrointestinal and Liver Diseases : Jgld. 22: 135-40. PMID 23799211 |
0.523 |
|
| 2013 |
Miheller P, Kiss LS, Mandel M, Lakatos PL. Methotrexate: should we start using it in clinical practice? Current Drug Targets. 14: 1480-9. PMID 23651163 DOI: 10.2174/13894501113149990604 |
0.619 |
|
| 2013 |
Lovasz BD, Lakatos L, Horvath A, Szita I, Pandur T, Mandel M, Vegh Z, Golovics PA, Mester G, Balogh M, Molnar C, Komaromi E, Kiss LS, Lakatos PL. Evolution of disease phenotype in adult and pediatric onset Crohn's disease in a population-based cohort. World Journal of Gastroenterology : Wjg. 19: 2217-26. PMID 23599648 DOI: 10.3748/Wjg.V19.I14.2217 |
0.615 |
|
| 2013 |
Lakatos PL, Vegh Z, Lovasz BD, David G, Pandur T, Erdelyi Z, Szita I, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Golovics PA, Mandel M, Horvath A, ... ... Kiss LS, et al. Is current smoking still an important environmental factor in inflammatory bowel diseases? Results from a population-based incident cohort. Inflammatory Bowel Diseases. 19: 1010-7. PMID 23399739 DOI: 10.1097/Mib.0B013E3182802B3E |
0.602 |
|
| 2013 |
Miheller P, Kiss LS, Juhasz M, Mandel M, Lakatos PL. Recommendations for identifying Crohn's disease patients with poor prognosis. Expert Review of Clinical Immunology. 9: 65-75; quiz 76. PMID 23256765 DOI: 10.1586/Eci.12.86 |
0.629 |
|
| 2013 |
Lakatos PL, Lovasz BD, David G, Pandur T, Erdelyi Z, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Golovics PA, Vegh Z, Mandel M, Horvath A, Szathmari M, ... Kiss LS, et al. The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases: results from a population-based cohort in Eastern Europe. Journal of Crohn's & Colitis. 7: 385-91. PMID 22766526 DOI: 10.1016/J.Crohns.2012.06.011 |
0.625 |
|
| 2013 |
Lovasz B, Mandel M, Kiss L, Golovics P, Vegh Z, Farkas K, Molnar T, Balint A, Mohas A, Szilagyi B, Fekete S, Lakatos P. Work disability in patients with inflammatory bowel diseases. preliminary report from two referral centers Zeitschrift FüR Gastroenterologie. 51. DOI: 10.1055/S-0033-1347492 |
0.508 |
|
| 2013 |
Lovasz B, Lakatos L, Golovics P, David G, Pandur T, Erdelyi Z, Mester G, Balogh M, Szita I, Molnar C, Komaromi E, Vegh Z, Mandel M, Kiss L, Lakatos P. Risk of colorectal cancer in CD patients with colonic involvement and stenosing disease. 1977 - 2012. Results from a population-based study Zeitschrift FüR Gastroenterologie. 51. DOI: 10.1055/S-0033-1347491 |
0.431 |
|
| 2013 |
Kiss L, Lovász B, Farkas K, Végh Z, Molnár T, Palatka K, Papp M, Mohás A, Szilágyi B, Fekete S, Mandel M, Golovics P, Lakatos P. Levels of anti-double-strand DNA but not antinuclear antibodies are associated with treatment efficacy and adverse outcomes in IBD patients treated with anti-TNF Zeitschrift FüR Gastroenterologie. 51. DOI: 10.1055/S-0033-1347483 |
0.318 |
|
| 2013 |
Golovics P, Mandel M, Lakatos L, Lovász B, Végh Z, Szita I, Mester G, Balogh M, Molnár C, Komáromi E, Mohás A, Szilágyi B, Fekete S, Kiss L, Lakatos P. Prevalence and predictors of hospitalization and re-hospitalization in Crohn's disease in a population based inception cohort between 2000 - 2012 Zeitschrift FüR Gastroenterologie. 51. DOI: 10.1055/S-0033-1347470 |
0.448 |
|
| 2013 |
Golovics P, Lakatos L, Lovasz B, David G, Pandur T, Erdelyi Z, Mester G, Balogh M, Szita I, Molnar C, Komaromi E, Vegh Z, Mandel M, Kiss L, Lakatos P. P624 Risk of colorectal cancer in CD patients with colonic involvement and stenosing disease. Results from a population-based study Journal of Crohn's and Colitis. 7: S261. DOI: 10.1016/S1873-9946(13)60645-5 |
0.56 |
|
| 2013 |
Lovasz B, Lakatos L, Golovics P, Horvath A, Szita I, Pandur T, Mandel M, Vegh Z, Mester G, Balogh M, Molnar C, Komaromi E, Kiss L, Lakatos P. P307 Age at diagnosis 40-years is not an accurate predictor of disease outcome in patients with Crohn's disease Journal of Crohn's and Colitis. 7: S132. DOI: 10.1016/S1873-9946(13)60328-1 |
0.55 |
|
| 2013 |
Kiss L, Lovasz B, Golovics P, Vegh Z, Farkas K, Molnar T, Palatka K, Mohas A, Szilagyi B, Fekete S, Lakatos P. P203 Levels of anti-double-strained DNA but not antinuclear antibodies in patients with IBD treated by anti-TNFs are associated with adverse outcomes Journal of Crohn's and Colitis. 7: S90. DOI: 10.1016/S1873-9946(13)60225-1 |
0.5 |
|
| 2013 |
Lovasz B, Mandel M, Kiss L, Golovics P, Vegh Z, Farkas K, Molnar T, Balint A, Mohas A, Szilagyi B, Fekete S, Lakatos P. P115 Work disability in patients with inflammatory bowel diseases. Preliminary report from two referral centers Journal of Crohn's and Colitis. 7: S55. DOI: 10.1016/S1873-9946(13)60137-3 |
0.607 |
|
| 2012 |
Lakatos PL, Lakatos L, Kiss LS, Peyrin-Biroulet L, Schoepfer A, Vavricka S. Treatment of extraintestinal manifestations in inflammatory bowel disease. Digestion. 86: 28-35. PMID 23051724 DOI: 10.1159/000341950 |
0.606 |
|
| 2012 |
Golovics PA, Lakatos PL, Dávid G, Pandur T, Erdélyi Z, Horváth A, Mester G, Balogh M, Szipocs I, Molnár C, Komáromi E, Lovász BD, Szathmári M, Kiss LS, Lakatos L. [The effect of early immunosuppressive therapy on the rate of resections performed in patients with Chron's disease, in Veszprém county, Hungary, a population-based cohort study]. Orvosi Hetilap. 153: 541-52. PMID 22450143 DOI: 10.1556/Oh.2012.29331 |
0.609 |
|
| 2012 |
Lakatos PL, Golovics PA, David G, Pandur T, Erdelyi Z, Horvath A, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Veres G, Lovasz BD, Szathmari M, Kiss LS, et al. Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009. The American Journal of Gastroenterology. 107: 579-88. PMID 22233693 DOI: 10.1038/Ajg.2011.448 |
0.569 |
|
| 2012 |
Miheller P, Kiss LS, Lorinczy K, Lakatos PL. Anti-TNF trough levels and detection of antibodies to anti-TNF in inflammatory bowel disease: are they ready for everyday clinical use? Expert Opinion On Biological Therapy. 12: 179-92. PMID 22149260 DOI: 10.1517/14712598.2012.644271 |
0.594 |
|
| 2012 |
Kiss LS, Papp M, Lovasz BD, Vegh Z, Golovics PA, Janka E, Varga E, Szathmari M, Lakatos PL. High-sensitivity C-reactive protein for identification of disease phenotype, active disease, and clinical relapses in Crohn's disease: a marker for patient classification? Inflammatory Bowel Diseases. 18: 1647-54. PMID 22081542 DOI: 10.1002/Ibd.21933 |
0.615 |
|
| 2012 |
Lovasz B, Lakatos L, Horvath A, Pandur T, Erdelyi Z, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Golovics P, Kiss L, Lakatos P. P109 Evolution of the disease behavior in pediatric and adult onset CD in a population-based incident cohort from Western Hungary Journal of Crohn's and Colitis. 6: S53-S54. DOI: 10.1055/S-0032-1312401 |
0.545 |
|
| 2012 |
Lakatos P, Lovász B, Horváth Á, Pandur T, Erdélyi Z, Mester G, Balogh M, Szipocs I, Molnár C, Komáromi E, Golovics P, Mandel M, Kiss L, Lakatos L. Low risk of lymphoma in inflammatory bowel diseases in western Hungary. Results from a population-based incident cohort Zeitschrift FüR Gastroenterologie. 50. DOI: 10.1055/S-0032-1312397 |
0.615 |
|
| 2012 |
Lakatos L, Golovics P, Dávid G, Pandur T, Erdélyi Z, Horváth Á, Mester G, Balogh M, Szipocs I, Molnár C, Komáromi E, Lovász B, Kiss L, Lakatos P. Is early surgery associated with a more benign disease course in Crohn's disease? Surgery rates in a population-based inception cohort from western Hungary between 1977-2009 Zeitschrift FüR Gastroenterologie. 50. DOI: 10.1055/S-0032-1312396 |
0.443 |
|
| 2012 |
Lakatos L, Pandur T, Erdelyi Z, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Lovasz B, Horvath A, Golovics P, Kiss L, Lakatos P. P411 Is smoking still an important environmental factor in inflammatory bowel diseases? Results from a population-based incident cohort Journal of Crohn's and Colitis. 6: S173. DOI: 10.1055/S-0032-1312377 |
0.571 |
|
| 2012 |
Lakatos L, Lovasz B, Horvath A, Pandur T, Erdelyi Z, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Golovics P, Kiss L, Lakatos P. P415 Low risk of lymphoma in inflammatory bowel diseases in Western Hungary. Results from a population-based incident cohort Journal of Crohn's and Colitis. 6: S175. DOI: 10.1016/S1873-9946(12)60434-6 |
0.611 |
|
| 2012 |
Lovasz B, Lakatos L, Horvath A, Pandur T, Erdelyi Z, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Veres G, Golovics P, Kiss L, Lakatos P. P410 Incidence rates and disease course of pediatric IBD in Western Hungary between 1977–2008 Journal of Crohn's and Colitis. 6: S173. DOI: 10.1016/S1873-9946(12)60429-2 |
0.517 |
|
| 2012 |
Golovics P, Lakatos L, David G, Pandur T, Erdelyi Z, Horvath A, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Lovasz B, Kiss L, Lakatos P. P108 Is early surgery associated with a more benign disease course in Crohn's disease? Surgery rates in a population-based inception cohort from Western Hungary between 1977–2009 Journal of Crohn's and Colitis. 6: S53. DOI: 10.1016/S1873-9946(12)60128-7 |
0.52 |
|
| 2012 |
Lovasz BD, Lakatos PL, Erdelyi Z, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Veres G, Golovics PA, Kiss LS, Lakatos L. Tu1275 Incidence Rates and Disease Course of Pediatric IBD in Western Hungary Between 1977-2008 Gastroenterology. 142: S-790. DOI: 10.1016/S0016-5085(12)63069-8 |
0.489 |
|
| 2012 |
Lakatos L, Golovics PA, Lovasz BD, Erdelyi Z, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Kiss LS, Lakatos PL. Sa1247 Low Risk of Lymphoma in Inflammatory Bowel Diseases in Western Hungary. Results From a Population-Based Incident Cohort Gastroenterology. 142: S-253. DOI: 10.1016/S0016-5085(12)60954-8 |
0.428 |
|
| 2012 |
Lovasz BD, Lakatos L, Erdelyi Z, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Golovics PA, Kiss LS, Lakatos PL. Sa1236 Evolution of the Disease Behavior in Pediatric and Adult Onset CD in a Population-Based Incident Cohort From Western Hungary Gastroenterology. 142: S-251. DOI: 10.1016/S0016-5085(12)60943-3 |
0.402 |
|
| 2012 |
Golovics PA, Lakatos L, Erdelyi Z, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Lovasz BD, Kiss LS, Lakatos PL. 1066 Is Early Surgery Associated With a More Benign Disease Course in Crohn's Disease? Surgery Rates in a Population-Based Inception Cohort From Western Hungary Between 1977-2009 Gastroenterology. 142: S-189. DOI: 10.1016/S0016-5085(12)60709-4 |
0.338 |
|
| 2011 |
Lakatos PL, Kiss LS. Current status of thiopurine analogues in the treatment in Crohn's disease. World Journal of Gastroenterology. 17: 4372-81. PMID 22110262 DOI: 10.3748/Wjg.V17.I39.4372 |
0.59 |
|
| 2011 |
Lakatos L, Kiss LS, David G, Pandur T, Erdelyi Z, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Lakatos PL. Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002-2006. Inflammatory Bowel Diseases. 17: 2558-65. PMID 22072315 DOI: 10.1002/Ibd.21607 |
0.661 |
|
| 2011 |
Kiss LS, Szamosi T, Molnar T, Miheller P, Lakatos L, Vincze A, Palatka K, Barta Z, Gasztonyi B, Salamon A, Horvath G, Tóth GT, Farkas K, Banai J, Tulassay Z, et al. Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's disease. Alimentary Pharmacology & Therapeutics. 34: 911-22. PMID 21883326 DOI: 10.1111/J.1365-2036.2011.04827.X |
0.583 |
|
| 2011 |
Kiss LS, Szamosi T, Molnár T, Miheller P, Lakatos L, Vincze A, Palatka K, Bartha Z, Gasztonyi B, Salamon A, Horváth G, Tóth GT, Farkas K, Banai J, Tulassay Z, et al. [Predictors of efficacy, mucosal healing and dose intensification during the first year of adalimumab therapy in patients with luminal and fistulizing Crohn's disease. National data from Hungary]. Orvosi Hetilap. 152: 1433-42. PMID 21865144 DOI: 10.1556/Oh.2011.29200 |
0.589 |
|
| 2011 |
Lakatos PL, Kiss LS, Miheller P. Nutritional influences in selected gastrointestinal diseases. Digestive Diseases (Basel, Switzerland). 29: 154-65. PMID 21734379 DOI: 10.1159/000323878 |
0.585 |
|
| 2011 |
Kiss LS, Lakatos PL. Natural history of ulcerative colitis: current knowledge. Current Drug Targets. 12: 1390-5. PMID 21466488 DOI: 10.2174/138945011796818117 |
0.595 |
|
| 2011 |
Lakatos PL, David G, Pandur T, Erdelyi Z, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Kiss LS, Lakatos L. Risk of colorectal cancer and small bowel adenocarcinoma in Crohn's disease: a population-based study from western Hungary 1977-2008. Journal of Crohn's & Colitis. 5: 122-8. PMID 21453881 DOI: 10.1055/S-0031-1278478 |
0.604 |
|
| 2011 |
Lakatos PL, David G, Pandur T, Erdelyi Z, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Kiss LS, Lakatos L. IBD in the elderly population: results from a population-based study in Western Hungary, 1977-2008. Journal of Crohn's & Colitis. 5: 5-13. PMID 21272797 DOI: 10.1016/J.Crohns.2010.08.004 |
0.588 |
|
| 2011 |
Lakatos PL, Kiss LS, Palatka K, Altorjay I, Antal-Szalmas P, Palyu E, Udvardy M, Molnar T, Farkas K, Veres G, Harsfalvi J, Papp J, Papp M. Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohn's disease. Inflammatory Bowel Diseases. 17: 767-77. PMID 20865702 DOI: 10.1002/Ibd.21402 |
0.61 |
|
| 2011 |
Lakatos P, Dávid G, Pandur T, Erdélyi Z, Mester G, Balogh M, Szipocs I, Molnár C, Komáromi E, Kiss L, Lakatos L. Is there a change in the natural history of Crohn's disease; surgical rates and medical management in a population-based inception cohort from western Hungary between 1977–2008 Zeitschrift Fur Gastroenterologie. 49. DOI: 10.1055/S-0031-1278479 |
0.416 |
|
| 2011 |
Kiss L, Papp M, Lovasz B, Vegh Z, Golovics P, Janka E, Varga E, Lakatos P. High-sensitivity CRP at diagnosis and during follow-up in patients with Crohn's disease: Is it a marker for patient classification? Zeitschrift FüR Gastroenterologie. 49. DOI: 10.1055/S-0031-1278471 |
0.457 |
|
| 2011 |
Kiss L, Miheller P, Molnár T, Lakatos L, Vincze Á, Palatka K, Gosztonyi B, Salamon Á, Horváth G, Farkas K, Szamosi T, Banai J, Tulassay Z, Papp M, Lakatos P. Predictors of efficacy, mucosal healing and dose intensification at 12-months of adalimumab therapy in patients with Crohn's disease. National data from Hungary Zeitschrift FüR Gastroenterologie. 49. DOI: 10.1055/S-0031-1278470 |
0.44 |
|
| 2011 |
Horvath A, Lakatos P, David G, Pandur T, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Kiss L, Lakatos L. Incidence and clinical phenotype of pediatric IBD in western Hungary, 1977–2008 Zeitschrift FüR Gastroenterologie. 49. DOI: 10.1055/S-0031-1278457 |
0.337 |
|
| 2011 |
Lakatos PL, Erdelyi Z, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Kiss LS, Lakatos L. Is There a Change in the Natural History of Crohn's Disease; Surgical Rates and Medical Management in a Population-Based Inception Cohort From Western Hungary Between 1977-2008 Gastroenterology. 140. DOI: 10.1016/S0016-5085(11)63238-1 |
0.419 |
|
| 2010 |
Lakatos PL, Czegledi Z, David G, Kispal Z, Kiss LS, Palatka K, Kristof T, Nagy F, Salamon A, Demeter P, Miheller P, Szamosi T, Banai J, Papp M, Bene L, et al. Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease. Journal of Crohn's & Colitis. 4: 283-90. PMID 21122517 DOI: 10.1016/J.Crohns.2009.11.011 |
0.637 |
|
| 2010 |
Meggyesi N, Kiss LS, Koszarska M, Bortlik M, Duricova D, Lakatos L, Molnar T, Leniček M, Vítek L, Altorjay I, Papp M, Tulassay Z, Miheller P, Papp J, Tordai A, et al. NKX2-3 and IRGM variants are associated with disease susceptibility to IBD in Eastern European patients. World Journal of Gastroenterology. 16: 5233-40. PMID 21049557 DOI: 10.3748/Wjg.V16.I41.5233 |
0.585 |
|
| 2010 |
Halászlaki C, Horváth H, Kiss L, Takács I, Speer G, Nagy Z, Winternitz T, Dabasi G, Zalatnai A, Patócs A, Lakatos P. [Verner-Morrison syndrome: a case study]. Orvosi Hetilap. 151: 1111-4. PMID 20558361 DOI: 10.1556/Oh.2010.28884 |
0.436 |
|
| 2010 |
Lakatos PL, Kiss LS. Is the disease course predictable in inflammatory bowel diseases? World Journal of Gastroenterology. 16: 2591-9. PMID 20518079 DOI: 10.3748/Wjg.V16.I21.2591 |
0.656 |
|
| 2010 |
Kiss LS, Lakatos PL. [Prediction of the disease course in inflammatory bowel diseases]. Orvosi Hetilap. 151: 293-301. PMID 20154000 DOI: 10.1556/Oh.2010.28813 |
0.651 |
|
| 2010 |
Lakatos L, Czeglédi Z, Dávid G, Kispál Z, Kiss LS, Palatka K, Kristóf T, Molnár T, Salamon A, Demeter P, Miheller P, Szamosi T, Banai J, Papp M, Bene L, et al. [Treatment adherence and use of complementary and alternative medicine in patients with inflammatory bowel disease]. Orvosi Hetilap. 151: 250-8. PMID 20133244 DOI: 10.1556/Oh.2010.28805 |
0.609 |
|
| 2010 |
Lakatos P, Meggyesi N, Kiss L, Koszarska M, Lakatos L, Molnar T, Altorjay I, Papp M, Tulassay Z, Miheller P, Papp J, Tordai A, Lukas M, Andrikovics H. NKX2–3 RS10883365 is associated with disease susceptibility to both Crohn's disease and ulcerative colitis while IRGM RS13361189 variant allele increased the risk for Crohn's disease in Eastern European patients Zeitschrift FüR Gastroenterologie. 48. DOI: 10.1055/S-0030-1254777 |
0.452 |
|
| 2010 |
Lakatos L, David G, Pandur T, Erdelyi Z, Mester G, Balogh M, Szipocs I, Molnar C, Horvath A, Komaromi E, Kiss L, Lakatos P. Incidence and early disease course of ulcerative colitis in Western Hungary between 2002–2006 Zeitschrift FüR Gastroenterologie. 48. DOI: 10.1055/S-0030-1254776 |
0.582 |
|
| 2010 |
Kiss L, Czegledi Z, Miheller P, Molnar T, Lakatos L, Palatka K, Farkas K, Szamosi T, Banai J, Tulassay Z, Papp M, Altojay I, Nagy F, Papp J, Lakatos P. Endoscopic outcome of medium term adalimumab therapy in patients with Crohn's disease. National data from Hungary Zeitschrift FüR Gastroenterologie. 48. DOI: 10.1055/S-0030-1254773 |
0.437 |
|
| 2010 |
Czegledi Z, Miheller P, Molnar T, Lakatos L, Vincze A, Palatka K, Gasztonyi B, Salamon A, Horvath G, Szamosi T, Tulassay Z, Papp M, Kiss L, Papp J, Lakatos P. Medium term efficacy and safety of adalimumab therapy in patients with Crohn's disease. national data from Hungary Zeitschrift FüR Gastroenterologie. 48. DOI: 10.1055/S-0030-1254751 |
0.41 |
|
| Show low-probability matches. |